4 ms·
Hi Kevin and Sam, I'm thinking about starting a company that extends the open-source concepts to the biology/pharmaceutical sphere. The concept is to make a m
by dnautics 11y ago
Hi Kevin and Sam,
I'm thinking about starting a company that extends the open-source concepts to the biology/pharmaceutical sphere. The concept is to make a modular, drug-producing microbial strain, and release that to researchers/industry under a permissive licence (e.g. bio equivalent of GPL). Monetization comes about by offering manufacturing services which cut the pain of 1) scaling and 2) getting "good manufacturing practice" regulatory clearance for clinical testing, and ultimately full consumer product.
Do you think there's VC interest in funding these sorts of ideas that have a somewhat riskier business model that also ultimately will extract a lower margin, but has a chance of changing the "way things are done"?